Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MCP3 | 24.0 | 64 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MCP3 | 25.0 | 78 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | MCP3 | 27.5 | 64 | |
RA2159 | Sigma A6730 | 3.0 | uM | 1 | MCP3 | 31.0 | 79 | ||||
N2586 | IL-6 | 100 | ug/mL | 1 | MCP3 | 62.0 | 77 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | MCP3 | 56.0 | 62 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MCP3 | 53.0 | 53 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MCP3 | 67.0 | 31 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | MCP3 | 54.0 | 68 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | MCP3 | 55.5 | 48 | |
N2586 | Sigma A6730 | 3.0 | uM | 1 | MCP3 | 73.0 | 37 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | MCP3 | 24.0 | 81 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | MCP3 | 27.0 | 67 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | MCP3 | 30.0 | 65 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | MCP3 | 29.0 | 78 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | MCP3 | 29.0 | 59 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | MCP3 | 27.0 | 65 | |
N2586 | IL-17A | 100 | ng/mL | 1 | MCP3 | 86.5 | 42 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | MCP3 | 72.0 | 44 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | MCP3 | 71.0 | 42 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | MCP3 | 57.0 | 51 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | MCP3 | 61.5 | 52 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | MCP3 | 73.0 | 45 | |
RA2159 | 1 | MCP3 | 24.0 | 56 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | MCP3 | 35.5 | 68 |